THE MEFV GENE PATHOGENIC VARIANTS
AND PHENOTYPE-GENOTYPE CORRELATION
IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER
IN THE ÇANAKKALE POPULATION
Battal F, Silan F, Topaloğlu N, Aylanç H, Yıldırım Ş,
Köksal Binnetoğlu F1, Tekin M1, Kaymaz N1, Ozdemir O,
*Corresponding Author: Assistant Professor Dr. Şule Yıldırım, Department of Pediatrics, Faculty of Medicine, Çanakkale
Onsekiz Mart University, Terzioğlu Yerleşkesi Ek Bina, 17100, Çanakkale, Turkey. Tel: +90-286-2180018/2107. Fax: +90-
286-263-59-56. E-mail: sule.yildirim@comu.edu.tr
page: 23
|
|
REFERENCES
1. Ozdemir O, Sezgin I, Kucuk KH, Candan F, Koksal B,
Sumer H, et al. Prevalence of known mutations in the
MEFV gene in a population screening with high rate
of carriers. Mol Biol Rep. 2011; 38(5): 3195-3200.
2. Ozalkaya E, Mir S, Sozeri B, Berdeli A, Mutlubas F,
Cura A. Familial Mediterranean fever gene mutation
frequencies and genotype-phenotype correlations in
the Aegean region of Turkey. Rheumatol Int. 2011;
31(6): 779-784.
3. Saatçi Ü, Bakkaloğlu A, Özen S, Beşbaş N. Familial
Mediterranean and amyloidosis in children. Acta
Paediatr. 1993; 82(8): 705-706.
4. Aldea A, Calafell F, Aróstegui JI, Lao O, Rius J, Plaza
S, et al. The west side story: MEFV haplotype in
Spanish FMF patients and controls, and evidence of
high LD and a recombination “hotspot” at the MEFV
locus. Hum Mutat. 2004; 23(4): 399-406.
5. Chae JJ, Wood G, Masters SL, Richard K, Park G,
Smith BJ, et al. The B30.2 domain of pyrin, the familial
Mediterranean fever protein, interacts directly
with caspase-1 to modulate IL-1β production. Proc
Natl Acad Sci USA. 2006; 103(26): 9982-9987.
6. Centola M, Wood G, Frucht DM, Galon J, Aringer M,
Farrell C, et al. The gene for familial Mediterranean
fever, MEFV, is expressed in early leucocyte development
and is regulated in response to inflammatory
mediators. Blood. 2000; 95(10): 3223-3231.
7. Deltas CC, Mean R, Rossou E, Costi C, Koupepidou
P, Hadjiyanni I, et al. Familial Mediterranean fever
(FMF) mutations occur frequently in the Greek-Cypriot
population of Cyprus. Genet Test. 2002; 6(1): 15-21.
8. Goulielmos GN, Fragouli E, Aksentijevich I, Sidiropoulos
P, Boumpas DT, Eliopoulos E. Mutational
analysis of the PRYSPRY domain of pyrin and implications
for familial Mediterranean fever (FMF). Biochem
Biophys Res Commun. 2006; 345(4): 1326-1332.
9. Majeed HA, El-Khateeb M, El-Shanti H, Rabaiha
ZA, Tayeh M, Najib D. The spectrum of familial
Mediterranean fever gene mutations in Arabs: Report
of a large series. Semin Arthritis Rheum. 2005; 34(6):
813-818.
10. Medlej-Hashim M, Serre JL, Corbani S, Saab O,
Jalkh N, Delague V, et al. Familial Mediterranean
fever (FMF) in Lebanon and Jordan: A population
genetics study and report of three novel mutations.
Eur J Med Genet. 2005; 48(4): 412-420.
11. Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A,
Shtrasburg S, et al. Evaluation of disease severity in
familial Mediterranean fever. Semin Arthritis Rheum.
2005; 35(1): 57-64.
12. The French FMF Consortium. A candidate gene for
familial Mediteranean fever. Nat Genet. 1997; 17(1):
25-31.
13. The International FMF Consortium. Ancient missense
mutations in a new member of the RoRet gene family
are likely the cause familial Mediteranean fever. Cell.
1997; 90(4): 797-807.
14. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner
DL, Pras M, et al. MEFV mutation analysis in patient
suffering from amyloidosis of Familial Medterranean
Fever. Amyloid. 1999; 6(1): 1-6.
15. Touitou I, Lesage S, McDermott M, Cuisset L, Hoffman
H, Dode C, et al. Infevers: An evolving mutation
database for auto-inflammatory syndromes. Hum
Mutat. 2004; 24(3): 194-198.
16. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur
O, Yalcinkaya F, et al.; Turkish FMF Study Group.
Familial Mediterranean fever (FMF) in Turkey: Results
of a nationwide multicenter study. Medicine
(Baltimore). 2005; 84(1): 1-11.
17. Zaks N, Shinar Y, Padeh S, Lidar M, Mor A, Tokov
I, et al. Analysis of the three most common MEFV
mutations in 412 patients with familial Mediterranean
fever. Med Assoc J. 2003; 5(8): 585-588.
18. Dewalle M, Domingo C, Rozenbaum M, Ben-Chétrit
E, Cattan D, Bernot A, et al. Genotype-phenotype
correlation in Jewish patients suffering from Familial
Mediterranean Fever (FMF). Eur J Hum Genet. 1998;
6(1): 95-97.
19. Goldfinger SE. Colchicine for familial Mediterranean
fever. N Eng J Med. 1972; 287(25): 1302.
20. Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich
I, Koziol DE, et al. Genotype-phenotype assessment
of common genotypes among patients with
familial Mediterranean fever. J Rheumatol. 2000;
27(7):1703-1707.
21. Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil
H, et al. Amyloidosis and its related factors in
Turkish patients with familial Mediterranean fever:
A multicentre study. Rheumatology (Oxford). 2014;
53(4): 741-745. doi:10.1093/rheumatology/ket400.
22. Yolbas I, Ozen F, Kocak N, Kelekci S, Gunes A,
Yel S. The frequency of MEFV gene mutation in
patients admitted to hospital with preliminary diagnosis
of familial mediterranean fever who undergone
a prior appendectomy. Eur Rev Med Pharmacol Sci.
2012;16(7): 949-951.
23. Sayarlioglu M, Cefle A, Inanc M, Kamali S, Dalkilic
E, Gul A, et al. Characteristics of patients with
adult-onset familial Mediterranean fever in Turkey:
Analysis of 401 cases. Int J Clin Pract. 2005; 59(2):
202-205.
24. Ülgenalp A. The distribution of MEFV of gene Mutations
in the referrals to DEGETAM. DEU Med School
J. 2009; 23(2): 53-58.
25. Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu
R, Besbas N, et al. Mutation frequency of Familial
Mediterranean Fever and evidence for a high carrier
rate in the Turkish population. Eur J Hum Genet.
2001; 9(7): 553-555.
26. Topaloglu R, Ozaltin F, Yilmaz E, Ozen S, Balci B,
Besbas N, et al. E148Q is a disease-causing MEFV
mutation: A phenotypic evaluation in patients with
familial Mediterranean fever. Ann Rheum Dis. 2005;
64(5): 750-752.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
